de Vries, C. R., Monken, C. E., & Lattime, E. C. (2015). The Addition of Recombinant Vaccinia HER2/neu to Oncolytic Vaccinia-GMCSF Given into the Tumor Microenvironment Overcomes MDSC-Mediated Immune Escape and Systemic Anergy. Cancer Gene Ther.
Chicago Style Citationde Vries, Christiaan R., Claude E. Monken, i Edmund C. Lattime. "The Addition of Recombinant Vaccinia HER2/neu to Oncolytic Vaccinia-GMCSF Given Into the Tumor Microenvironment Overcomes MDSC-Mediated Immune Escape and Systemic Anergy." Cancer Gene Ther 2015.
Cita MLAde Vries, Christiaan R., Claude E. Monken, i Edmund C. Lattime. "The Addition of Recombinant Vaccinia HER2/neu to Oncolytic Vaccinia-GMCSF Given Into the Tumor Microenvironment Overcomes MDSC-Mediated Immune Escape and Systemic Anergy." Cancer Gene Ther 2015.